Laurie Tylaska
- Oncology top 10%
- Immunology
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Pharmacology top 5%
- Co-authors
- Sumathy MathialaganRonald P. GladueManthena V. S. VarmaYi‐An BiJian LinHans‐Peter GerberBingwen LuEdward Rosfjord
- Topics
- Drug Transport and Resistance Mechanisms (7 papers)Chemokine receptors and signaling (7 papers)Immunotherapy and Immune Responses (4 papers)
- Cited by
- OncologyPharmacologyImmunology
- Partner nations
- United StatesAustraliaFinland
In The Last Decade
Laurie Tylaska
19 papers receiving 613 citations
Peers
Comparison fields: 5 of 72
- Oncology 432
- Immunology 144
- Molecular Biology 132
- Radiology, Nuclear Medicine and Imaging 125
- Pharmacology 123
Countries citing papers authored by Laurie Tylaska
This map shows the geographic impact of Laurie Tylaska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie Tylaska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie Tylaska more than expected).
Fields of papers citing papers by Laurie Tylaska
This network shows the impact of papers produced by Laurie Tylaska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie Tylaska. The network helps show where Laurie Tylaska may publish in the future.
Co-authorship network of co-authors of Laurie Tylaska
This figure shows the co-authorship network connecting the top 25 collaborators of Laurie Tylaska. A scholar is included among the top collaborators of Laurie Tylaska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie Tylaska. Laurie Tylaska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 66 | |
| 4 | 2 | |
| 5 | 46 | |
| 6 | 32 | |
| 7 | 42 | |
| 8 | 2 | |
| 9 | 155 | |
| 10 | 20 | |
| 11 | 11 | |
| 12 | 3 | |
| 13 | 13 | |
| 14 | 33 | |
| 15 | 17 | |
| 16 | 17 | |
| 17 | 39 | |
| 18 | 59 | |
| 19 | 55 |
About Laurie Tylaska
Laurie Tylaska is a scholar working on Oncology, Immunology and Allergy and Pharmacology, having authored 19 papers that have together received 623 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Chemokine receptors and signaling (7 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Oncology (432 citations), Pharmacology (123 citations) and Immunology (144 citations). Laurie Tylaska has collaborated with scholars based in United States, Australia and Finland. Frequent co-authors include Sumathy Mathialagan, Ronald P. Gladue, Manthena V. S. Varma, Yi‐An Bi, Jian Lin, Hans‐Peter Gerber, Bingwen Lu, Edward Rosfjord, Xingzhi Tan and Emi Kimoto. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.